معرفی
Aurélie Mahalatchimy is a permanent Researcher at the French National Center for Scientific Research (CNRS), affiliated with Aix Marseille University, Toulon University, and Pau & Pays Adour University. She works within the International, Comparative and European Laws (DICE-CERIC) research laboratory in Aix-en-Provence, France. Additionally, she serves as an Associated Researcher at the Center for Global Health Policy, School of Global Studies, University of Sussex, UK.
Dr. Mahalatchimy holds a PhD in Law from the University of Toulouse, France. Her academic journey has led her to become a prominent scholar in the field of biomedical law and regulation.
Her research primarily focuses on the International, European, and Comparative law of biomedical innovations, with particular emphasis on the legal frameworks governing human genes, cells, and tissues used for therapeutic purposes (specifically Advanced Therapy Medicinal Products), as well as for scientific, commercial, and industrial applications. Dr. Mahalatchimy's work bridges the gap between legal scholarship and practical regulatory challenges in emerging biomedical technologies, examining issues such as pharmaceutical regulation, biobanks, gene editing, organoids, and transhumanism.
Analysis of her recent publications reveals a strong focus on Advanced Therapy Medicinal Products (ATMPs) regulation, biolaw conceptual frameworks, and the evolving European regulatory landscape for innovative medicines. Her scholarly output demonstrates increasing attention to practical implementation challenges of EU regulations, particularly concerning cell and gene therapies, with recent work examining hospital exemption pathways, manufacturing practices, data governance issues, and the development of practical guidance resources for researchers and developers across Europe.
Dr. Mahalatchimy has been actively involved in numerous European research projects including EuroGCT, I-Biolex, ORGANACT, and the European Association of Health Law initiatives. Her collaborative approach is evident through her extensive co-authorship network, particularly with researchers from the DICE-CERIC laboratory and European regulatory experts.
She leads and contributes to interdisciplinary research teams focused on mapping regulatory landscapes, developing practical guidance for researchers, and examining the ethical and legal dimensions of emerging biomedical technologies. Her work with the EuroGCT project has been particularly influential in creating resources for cell and gene therapy developers across Europe, including searchable maps, regulatory guidance, and practical implementation tools.
